# Clustering Approach 4 : MRNASEQ_CNMF
Index	Clinical feature name	Test type	P value	Comment
1	Time to Death	logrank test	1.02612072480079e-05	Range of duration = 0.03 to 223.96, nDeath = 66, nCensor = 119
2	AGE	ANOVA	0.0162607796366793	Range of values = 41 to 86, Mean = 65.9293, StdDev = 9.45512, nMissing = 26
3	GENDER	Chi-square test	0.0312742236334106	nTypes = 2 (FEMALE/MALE), nPatients = 97/113
4	KARNOFSKY.PERFORMANCE.SCORE	ANOVA	0.861726194725466	Range of values = 0 to 100, Mean = 70.7143, StdDev = 39.3142, nMissing = 196
5	HISTOLOGICAL.TYPE	Chi-square test	0.165660420524914	nTypes = 11 (LUNG ACINAR ADENOCARCINOMA/LUNG ADENOCARCINOMA MIXED SUBTYPE/LUNG ADENOCARCINOMA- NOT OTHERWISE SPECIFIED (NOS)/LUNG BRONCHIOLOALVEOLAR CARCINOMA MUCINOUS/LUNG BRONCHIOLOALVEOLAR CARCINOMA NONMUCINOUS/LUNG CLEAR CELL ADENOCARCINOMA/LUNG MICROPAPILLARY ADENOCARCINOMA/LUNG MUCINOUS ADENOCARCINOMA/LUNG PAPILLARY ADENOCARCINOMA/LUNG SOLID PATTERN PREDOMINANT ADENOCARCINOMA/MUCINOUS (COLLOID) ADENOCARCINOMA), nPatients = 3/50/128/3/8/2/2/2/9/1/2
6	PATHOLOGY.T	Chi-square test	0.18510716925813	nTypes = 4 (T1/T2/T3/T4), nPatients = 46/132/19/12, nMissing = 1
7	PATHOLOGY.N	Chi-square test	0.000759863202136441	nTypes = 3 (N0/N1/N2+N3), nPatients = 116/47/42, nMissing = 5
8	PATHOLOGICSPREAD(M)	Chi-square test	0.483585694560014	nTypes = 3 (M0/M1/MX), nPatients = 154/10/40, nMissing = 6
9	RADIATIONS.RADIATION.REGIMENINDICATION	Chi-square test	0.689352590766725	nTypes = 2 (NO/YES), nPatients = 199/11
10	NEOADJUVANT.THERAPY	Chi-square test	0.0683166692097671	nTypes = 2 (NO/YES), nPatients = 176/34
